Palvella Therapeutics, Inc. (FRA:PI6)
Germany
· Delayed Price · Currency is EUR 79.50
-1.00 (-1.24%)
Last updated: Dec 5, 2025, 8:04 AM CET
Palvella Therapeutics Statistics
Total Valuation
FRA:PI6 has a market cap or net worth of EUR 952.05 million. The enterprise value is 911.28 million.
| Market Cap | 952.05M |
| Enterprise Value | 911.28M |
Important Dates
The next estimated earnings date is Tuesday, March 31, 2026.
| Earnings Date | Mar 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 11.84M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +60.51% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 16.76% |
| Owned by Institutions (%) | 54.44% |
| Float | 6.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 28.88 |
| P/TBV Ratio | 28.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -33.03 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.49, with a Debt / Equity ratio of 0.41.
| Current Ratio | 6.49 |
| Quick Ratio | 6.38 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.88 |
Financial Efficiency
Return on equity (ROE) is -301.19% and return on invested capital (ROIC) is -63.87%.
| Return on Equity (ROE) | -301.19% |
| Return on Assets (ROA) | -47.54% |
| Return on Invested Capital (ROIC) | -63.87% |
| Return on Capital Employed (ROCE) | -55.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.97M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 67.26 |
| 200-Day Moving Average | 37.50 |
| Relative Strength Index (RSI) | 57.52 |
| Average Volume (20 Days) | 14 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.30 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -26.99M |
| Pretax Income | -28.08M |
| Net Income | -27.59M |
| EBITDA | n/a |
| EBIT | -26.99M |
| Earnings Per Share (EPS) | -3.00 |
Balance Sheet
The company has 54.18 million in cash and 13.65 million in debt, giving a net cash position of 40.52 million.
| Cash & Cash Equivalents | 54.18M |
| Total Debt | 13.65M |
| Net Cash | 40.52M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 32.97M |
| Book Value Per Share | 2.97 |
| Working Capital | 48.26M |
Cash Flow
| Operating Cash Flow | -21.71M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:PI6 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -60.51% |
| Shareholder Yield | -60.51% |
| Earnings Yield | -2.90% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |